Intrinsiqq
Tenet Healthcare Corporation logo

Tenet Healthcare Corporation (THC) Insider Trading

Last 12 months

Insiders sold $71.7M and bought nothing on the open market.

None of the selling was scheduled in advance under a 10b5-1 plan. CEO Saumya Sutaria sold $27.6M on Aug 25, 19% of their stake, outside a plan. The last open-market buy by an executive or director was in Oct 2022.

Net open-market
−$71.7M
0 buys · 23 sales
Under a 10b5-1 plan
0%
of the value sold
Insiders who bought / sold
0 / 14
executives and directors
Last open-market buy
Oct 2022
Oct 26, 2022

Get an email when THC's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

  • Sep 14No plan
    J Robert Kerrey
    Director · sold 12,010 at avg $263.72
    $3.17M
    71% of stake
  • Sep 10No plan
    Richard J Mark
    Director · sold 10,000 at $263.42
    $2.63M
    28% of stake
  • Sep 2No plan
    Nadja West
    Director · sold 1,152 at $258.80
    $298k
    4.6% of stake
  • Aug 31No plan
    Lisa Y Foo
    EVP, Chief Operating Officer · sold 24,000 at $266.32
    $6.39M
    75% of stake
  • Aug 24 – 25No plan
    Saumya Sutaria
    CEO · sold 100,000 at avg $276.36
    $27.6M
    19% of stake
  • Aug 24No plan
    Cecil D Haney
    Director · sold 1,300 at $278.03
    $361k
    9.4% of stake
  • Aug 6 – 7No plan
    Tammy Romo
    Director · sold 7,422 at avg $263.03
    $1.95M
    21% of stake
  • Aug 5No plan
    Roy Blunt
    Director · sold 600 at $262.68
    $158k
    12% of stake
  • Jul 29No plan
    Lisa Y Foo
    EVP, Chief Operating Officer · sold 10,000 at $258.03
    $2.58M
    24% of stake
  • Jul 27No plan
    Christopher S. Lynch
    Director · sold 3,837 at $243.44
    $934k
    29% of stake
  • Jul 27No plan
    Paola M Arbour
    EVP, Chief Information Officer · sold 10,878 at $243.90
    $2.65M
    37% of stake
  • Jul 27No plan
    James L Bierman
    Director · sold 5,000 at $244.96
    $1.22M
    14% of stake
  • May 28No plan
    J Robert Kerrey
    Director · sold 5,638 at avg $174.52
    $984k
    25% of stake
  • May 27No plan
    Nadja West
    Director · sold 3,000 at $177.35
    $532k
    11% of stake
  • Mar 11No plan
    Paola M Arbour
    EVP, Chief Information Officer · sold 6,500 at $238.43
    $1.55M
    18% of stake
  • Mar 9No plan
    Thomas W Arnst
    EVP, Chief Admin. Officer & GC · sold 8,000 at avg $238.85
    $1.91M
    100% of stake
  • Mar 2No plan
    R. Scott Ramsey
    Principal Accounting Officer · sold 8,017 at avg $232.70
    $1.87M
    100% of stake
  • Mar 2No plan
    Thomas W Arnst
    EVP, Chief Admin. Officer & GC · sold 24,000 at $234.04
    $5.62M
    75% of stake
  • Dec 15, 2025No plan
    Nadja West
    Director · sold 2,178 at $197.47
    $430k
    7.1% of stake
  • Nov 6, 2025No plan
    R. Scott Ramsey
    Principal Accounting Officer · sold 13,322 at avg $205.11
    $2.73M
    100% of stake
  • Nov 5, 2025No plan
    Tammy Romo
    Director · sold 645 at $205.20
    $132k
    1.8% of stake
  • Nov 3, 2025 – Nov 4, 2025No plan
    Tammy Romo
    Director · sold 26,855 at avg $202.23
    $5.43M
    43% of stake
  • Oct 29, 2025No plan
    Richard W Fisher
    Director · sold 2,500 at $208.43
    $521k
    22% of stake
  • Sep 10, 2025No plan
    Saumya Sutaria
    CEO · sold 78,762 at avg $190.78
    $15M
    18% of stake
  • Aug 28, 2025No plan
    Christopher S. Lynch
    Director · sold 8 at $183.44
    $1k
    <0.1% of stake
  • Aug 20, 2025No plan
    Lisa Y Foo
    EVP, Chief Operating Officer · sold 8,000 at $179.53
    $1.44M
    28% of stake
  • Aug 19, 2025No plan
    Christopher S. Lynch
    Director · sold 3,952 at $176.39
    $697k
    24% of stake
  • Jun 5, 2025No plan
    Richard W Fisher
    Director · sold 836 at $173.16
    $145k
    6.9% of stake
  • Jun 5, 2025No plan
    Paola M Arbour
    EVP, Chief Information Officer · sold 7,738 at $173.00
    $1.34M
    28% of stake
  • May 29, 202510b5-1 plan
    James L Bierman
    Director · sold 4,613 at $170.00
    $784k
    12% of stake
  • May 27, 2025No plan
    J Robert Kerrey
    Director · sold 1,222 at $164.96
    $202k
    5.2% of stake
  • May 27, 2025No plan
    Richard W Fisher
    Director · sold 3,077 at $165.72
    $510k
    20% of stake
  • May 27, 202510b5-1 plan
    James L Bierman
    Director · sold 1,551 at $165.72
    $257k
    3.7% of stake
  • May 23, 202510b5-1 plan
    James L Bierman
    Director · sold 13,836 at avg $159.58
    $2.21M
    25% of stake
  • May 21, 2025No plan
    Thomas W Arnst
    EVP, Chief Admin. Officer & GC · sold 9,786 at $166.00
    $1.62M
    100% of stake
  • May 15, 2025No plan
    Paola M Arbour
    EVP, Chief Information Officer · sold 6,461 at $160.20
    $1.04M
    19% of stake
  • May 9, 2025No plan
    J Robert Kerrey
    Director · sold 5,001 at avg $148.50
    $743k
    18% of stake
  • Mar 11, 2025No plan
    J Robert Kerrey
    Director · sold 9,525 at avg $125.43
    $1.19M
    26% of stake
  • Mar 4, 2025No plan
    Cecil D Haney
    Director · sold 2,500 at $124.26
    $311k
    17% of stake
  • Oct 31, 2024No plan
    Lisa Y Foo
    EVP, Commercial Ops · sold 4,000 at avg $155.94
    $624k
    20% of stake
How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch THC, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Related stocks: Services-General Medical & Surgical Hospitals, NEC

Spot a number that looks wrong? Check it in THC's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing THC

Create a free account and get 14 days of Premium: every stock and every tool.

  • Unlimited stocks
  • Stock screener
  • Portfolio tracker
  • Editable DCF
  • Compare side by side
  • Unlimited alerts

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

SectorsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.